PROVIDER PROFILE · NPI 1578598967
Patrick DemarcoMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
915
Unique beneficiaries
—
Total services
14,757
Distinct HCPCS
14
Medicare payment
$252K
Peer benchmark
Total Medicare services vs. 196 Allergy/ Immunology providers in FL — top quintile (cohort median 5,512).
PRESCRIBING · PART D · 2024
Total Rx claims
1,310
Beneficiaries
—
Total drug cost
$654K
Distinct drugs
19
Brand share
38.0%
Top prescribed drugs
Fluticasone Propionate198 claims
Montelukast Sodium165 claims
Ipratropium Bromide131 claims
Fluticasone/Umeclidin/Vilanter129 claims
Azelastine Hcl124 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
57.5
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
85
By payment type
Food and Beverage$2K
Education$141
Top paying entities
Food and Beverage$2K
Education$141
REFERRAL NETWORK
Where Patrick Demarco's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Clinical Laboratory · Tampa, FL | 12 | 34 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE